Cargando…

Inhibition of LTA4H by bestatin in human and mouse colorectal cancer

BACKGROUND: Our preclinical data showed that the leukotriene A4 hydrolase (LTA4H) pathway plays a role in colorectal cancer (CRC). High expression of LTA4H and leukotriene B4 receptor type 1 (BLT1) were also associated with CRC survival probability. Clinical samples were evaluated to determine wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Simin, Yao, Ke, Li, Dan, Liu, Kangdong, Jin, Guoguo, Yan, Mingyang, Wu, Qiong, Chen, Hanyong, Shin, Seung Ho, Bai, Ruihua, Wang, Gangcheng, Bode, Ann M., Dong, Ziming, Guo, Zhiping, Dong, Zigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604047/ https://www.ncbi.nlm.nih.gov/pubmed/31085102 http://dx.doi.org/10.1016/j.ebiom.2019.05.008

Ejemplares similares

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model
por: Jin, Guoguo, et al.
Publicado: (2017)

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
por: Zhang, Yi, et al.
Publicado: (2015)

PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts
por: Sheng, Yuqiao, et al.
Publicado: (2016)

The Analgesic Activity of Bestatin as a Potent APN Inhibitor
por: Jia, Mei-Rong, et al.
Publicado: (2010)

Inhibition of Tumor Cell Invasion by Ubenimex (Bestatin) in vitro
por: Saiki, Ikuo, et al.
Publicado: (1989)

Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2
por: Wang, Li, et al.
Publicado: (2018)

A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo
por: Shin, Seung Ho, et al.
Publicado: (2017)

Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
por: Yeung, Yiu To, et al.
Publicado: (2018)

Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection
por: Pulido-Cejudo, Gabriel, et al.
Publicado: (1997)

The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis
por: Zykova, Tatyana A., et al.
Publicado: (2017)

Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19
por: Lu, Ning, et al.
Publicado: (2022)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC
por: Cao, Jiangying, et al.
Publicado: (2020)

Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance()()()
por: Li, Haitao, et al.
Publicado: (2014)

Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
por: Yang, Yi, et al.
Publicado: (2017)

Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression
por: Li, Haitao, et al.
Publicado: (2015)

Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions
por: Grujić, Mirjana, et al.
Publicado: (2002)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Crystal structure of the human PRPK–TPRKB complex
por: Li, Jian, et al.
Publicado: (2021)

Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.
por: Zhao, Ran, et al.
Publicado: (2020)

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model
por: Gu, Tingxuan, et al.
Publicado: (2021)

RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation
por: Yao, Ke, et al.
Publicado: (2018)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017)

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer
por: Liu, Hui, et al.
Publicado: (2020)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods
por: Chen, Hanyong, et al.
Publicado: (2012)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma
por: Liu, Fangfang, et al.
Publicado: (2021)

A natural small molecule, catechol, induces c-Myc degradation by directly targeting ERK2 in lung cancer
por: Lim, Do Young, et al.
Publicado: (2016)

Inhibition of aminopeptidases N, A and W: A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme
por: Tieku, Stephen, et al.
Publicado: (1992)

Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro
por: Bourinbaiar, A.S., et al.
Publicado: (1994)

Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2020)

TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019)

The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
por: Liu, Hui, et al.
Publicado: (2021)

Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines
por: Kim, Hyeong Won, et al.
Publicado: (2023)

Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts
por: Ma, Fayang, et al.
Publicado: (2021)

Precision medicine: the foundation of future cancer therapeutics
por: Shin, Seung Ho, et al.
Publicado: (2017)

Addressing the challenges of applying precision oncology
por: Shin, Seung Ho, et al.
Publicado: (2017)

Staphylococcal LTA antagonizes the B cell-mitogenic potential of LPS
por: Kang, Seok-Seong, et al.
Publicado: (2018)

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo
por: Ma, Fayang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vq70u5o9kla5hl2t8btq6ibkra